INSULET CORP
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| INSULET CORPORATION (Registrant) | |
| February 20, 2025 | /s/ James R. Hollingshead |
|---|---|
| James R. Hollingshead | |
| Chief Executive Officer(Principal Executive Officer) |
| February 20, 2025 | /s/ Ana M. Chadwick |
|---|---|
| Ana M. Chadwick | |
| Chief Financial Officer, Executive Vice President(Principal Financial Officer) |
POWER OF ATTORNEY AND SIGNATURES
We, the undersigned officers and directors of Insulet Corporation, hereby severally constitute and appoint James R. Hollingshead and Ana M. Chadwick, and each of them singly, our true and lawful attorneys, with full power to them and each of them singly, to sign for us in our names in the capacities indicated below, on all amendments to this Report, and generally to do all things in our names and on our behalf in such capacities to enable Insulet Corporation to comply with the provisions of the Securities Exchange Act of 1934, as amended, and all requirements of the Securities and Exchange Commission.
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities on February 20, 2025.
| Signature | Title |
|---|---|
| /s/ James R. Hollingshead | Chief Executive Officer |
| James R. Hollingshead | (Principal Executive Officer) |
| /s/ Ana M. Chadwick | Chief Financial Officer, Executive Vice President |
| Ana M. Chadwick | (Principal Financial Officer) |
| /s/ Luciana Borio, M.D. | |
| Luciana Borio, M.D. | Director |
| /s/ Wayne A.I. Frederick, M.D. | |
| Wayne A.I. Frederick, M.D. | Director |
| /s/ Jessica Hopfield | |
| Jessica Hopfield | Director |
| /s/ Michael R. Minogue | |
| Michael R. Minogue | Director |
| /s/ Flavia H. Pease | |
| Flavia H. Pease | Director |
| /s/ Timothy J. Scannell | |
| Timothy J. Scannell | Director |
| /s/ Timothy C. Stonesifer | |
| Timothy C. Stonesifer | Director |
| /s/ Elizabeth H. Weatherman | |
| Elizabeth H. Weatherman | Director |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.